Sobotka Glenn 4
4 · Astrana Health, Inc. · Filed Mar 30, 2026
Research Summary
AI-generated summary of this filing
Astrana (ASTH) CAO Glenn Sobotka Surrenders 662 Shares
What Happened
Glenn Sobotka, Chief Accounting Officer of Astrana Health, surrendered 662 shares on March 26, 2026, at a reported price of $24.27 per share to satisfy tax withholding obligations tied to restricted stock that vested the same day. The shares were disposed under transaction code F (tax withholding), with a total value of approximately $16,067. This was a share surrender to cover taxes, not an open-market sale.
Key Details
- Transaction date: March 26, 2026; Report filed: March 30, 2026 (filed 4 days after the transaction; Form 4s are typically due within two business days).
- Price and amount: 662 shares at $24.27 per share; total ≈ $16,067.
- Transaction type: F — shares surrendered/forfeited to cover tax withholding on vested restricted stock.
- Shares owned after transaction: Not specified in the filing provided.
- Footnotes: F1 confirms the 662-share surrender offset tax withholding for restricted stock that vested 3/26/2026. F2 notes additional restricted stock awards: 4,824 shares vest in three equal annual installments beginning 3/26/2027 (subject to continued employment), and 8,269 shares vest based on performance goals.
Context
Share surrenders to cover taxes on vested awards are routine and do not necessarily indicate insider buying or selling intent in the open market. The filing shows ongoing compensation-related equity (time- and performance-based restricted stock) that remains subject to vesting conditions.
Insider Transaction Report
- Tax Payment
Common Stock
[F1][F2]2026-03-26$24.27/sh−662$16,067→ 14,039 total
Footnotes (2)
- [F1]Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 26, 2026.
- [F2]Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 4,824 shares, which will vest in three equal annual installments beginning on March 26, 2027; and (ii) 8,269 shares, which will vest subject to the achievement of certain performance goals.